Leitl Daniela, Glöckl Rainer
Forschungsinstitut für pneumologische Rehabilitation, Schön Klinik Berchtesgadener Land, Malterhöh 1, 83471 Schönau am Königssee, Deutschland.
Pneumologische Rehabilitation, Deutsches Zentrum für Lungenforschung, Philipps-Universität Marburg, Marburg, Deutschland.
Pneumologe (Berl). 2022;19(3):130-141. doi: 10.1007/s10405-021-00431-z. Epub 2022 Jan 18.
Pulmonary rehabilitation (PR) is an evidence-based multidisciplinary treatment for patients with chronic respiratory diseases. The indications for PR prescription are given if there is a rehabilitation capability, a need for rehabilitation and a beneficial rehabilitation prognosis. The aims of PR are to reduce symptoms and to improve the quality of life and the patients' physical capacity. The effectiveness of PR is well-proven for patients with chronic obstructive pulmonary disease (COPD) at the highest level of evidence and for non-COPD patients with an increasing level of evidence based on randomized controlled trials and meta-analyses. The treatment content of PR is individually adapted to the patients' needs by a multimodal and multidisciplinary treatment team. To maintain the rehabilitation benefits of PR there is the possibility to participate in outpatient follow-up programs as well as to use digital technologies.
肺康复（PR）是一种针对慢性呼吸道疾病患者的循证多学科治疗方法。如果具备康复能力、有康复需求且康复预后良好，就可以开具PR处方。PR的目标是减轻症状、提高生活质量和患者的身体能力。基于随机对照试验和荟萃分析，PR对慢性阻塞性肺疾病（COPD）患者的有效性在最高证据水平上得到了充分证明，对非COPD患者的有效性证据水平也在不断提高。PR的治疗内容由多模式、多学科治疗团队根据患者的需求进行个性化调整。为了维持PR的康复效果，可以参加门诊随访项目以及使用数字技术。
